Danielle Brandman, M.D., M.A.S.
Assistant Professor of Medicine
Hepatology and Liver Transplantation
Department of Medicine
Hepatology and Liver Transplantation
Department of Medicine
Contact Information
Division of Gastroenterology
513 Parnassus Avenue, Room S-357
San Francisco, CA 94143-0358
(415) 514-1094 - Phone
(415) 476-0659 - Fax
Danielle.Brandman@ucsf.edu
Education
Boston University, B.A., Biology and Psychology, 1995-1999
UMDNJ-New Jersey Medical School, M.D., 2001-2005
University of California, San Francisco, M.A.S., Clinical Research, 2009-2011
Residencies
- University of California, San Francisco, Intern, Medicine, 2005-2006
- University of California, San Francisco, Resident, Medicine, 2006-2008
Fellowships
- University of California, San Francisco, Fellow, Gastroenterology, 2008-2011
- University of California, San Francisco, Fellow, Transplant Hepatology, 2011-2012
Board Certifications
- American Board of Internal Medicine
- American Board of Internal Medicine - Gastroenterology
Program Affiliations
- UCSF Liver Center
Clinical Expertise
- Acute Liver Failure (ALF)
- Alcoholic Liver Disease
- Autoimmune Hepatitis
- Choledochal Cysts
- Cirrhosis
- Hemochromatosis
- Hepatitis B
- Hepatitis C
- Hepatocellular Carcinoma (Primary Liver Cancer)
- Liver Transplantation
- Living Donor Liver Transplantation
- Non-alcoholic Fatty Liver Disease
- Polycystic Liver Disease
- Primary Biliary Cirrhosis
- Primary Sclerosing Cholangitis
- Toxic Hepatitis
Research Interests
- Hepatitis C virus (HCV)
- Liver injury and repair (Liver transplantation)
- Nonalcoholic steatohepatitis (NASH)
Biography
Dr. Danielle Brandman is an Assistant Professor of Medicine and hepatologist, specializing in treating patients needing liver transplants. Her research interests include nonalcoholic fatty liver disease and post-transplant metabolic syndrome. She engages in outcomes-based research with a special interest in NAFLD and liver transplantation: the post-transplant outcomes of patients with NAFLD, selection of patients with NAFLD for transplant, recurrence of NAFLD following transplant, and new-onset NAFLD after liver transplantation for other causes of liver disease
Dr. Brandman received her medical degree at UMDNJ New Jersey Medical School in 2005. She continued her medical training at University of California, San Francisco, where she completed her residency, gastroenterology fellowship, transplant hepatology fellowship, and master's degree in clinical research. Dr. Brandman is certified by the American Board of Internal Medicine in internal medicine and gastroenterology. She is a member of the American Association for the Study of Liver Disease (AASLD).
Awards & Honors
Publications
MOST RECENT PUBLICATIONS FROM A TOTAL OF 24
- Xu CQ, Zhou K, Brandman D. The Updated US Preventive Services Task Force Hepatitis B Screening Recommendations-Staying Committed. JAMA Intern Med. 2020 Dec 15. View in PubMed
- Price JC, Brandman D. Updated Hepatitis C Virus Screening Recommendation-A Step Forward. JAMA Intern Med. 2020 05 01; 180(5):637-639. View in PubMed
- Brandman D. Who Should Treat Fatty Liver Disease: Primary Care or Hepatology? Clin Liver Dis (Hoboken). 2019 Jun; 13(6):158-161. View in PubMed
- Adler E, Brandman D. Treatment of Fatty Liver Disease-Time to Implement Common Sense Measures. JAMA Intern Med. 2019 Jul 01. View in PubMed
- Brandman D, Lin H, McManus A, Agarwal S, Gache LM, Irish W, Gollob J, Živkovic SA. Evaluating Prognostic Factors for Liver Transplantation Among United States Patients With Hereditary Transthyretin-Mediated (hATTR) Amyloidosis Using National Registry Data. Prog Transplant. 2019 09; 29(3):213-219. View in PubMed
- View All Publications
In the News
- UCSF General Surgery Residency Program - - October 16, 2020Hillary Braun, M.D., a general surgery research resident, was named the 2020 Bruce A. Luxon Emerging Liver Scholar by the American Association for the Study of Liver Diseases (AASLD). The Emerging Liver Scholars program selects 20 medicine or surgery residents who are interested in the study of liver diseases to participate in a curated program at the AASLD's annual Liver Meeting, which will be held virtually this year November 13-16, 2020. In addition to participation in the Emerging Liver [...]
